Skip to content
★ Sign in to follow
JM

James M. Denny

GATX CorpGilead Sciences, Inc.Choicepoint Inc
Total declarations
312
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (259 ops.)
€34.9M

Latest filing published 20 Dec 2012 for Gilead Sciences, INC..

Filing timeline

BuySale
James M. Denny

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
259
Signal history

No signal scores available.

James M. Denny: trading record in brief

This profile gathers the share dealings of James M. Denny across 3 companies, led by Gilead Sciences, Inc., GATX Corp and Choicepoint Inc. Over a trading history stretching from 1 February 2006 to 28 November 2012, the count stands at 312 filings.

Every open-market trade on record is a sale: 259 sales worth €34.9M. Outside the open market, there are 16 share grants and 31 option exercises. So far in 2012, the count stands at no purchases and 1 sale.

The newest entry dates from 20 December 2012: a transaction, in Gilead Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to James M. Denny

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations311 total

25 of 311 declarations